XML 16 R5.htm IDEA: XBRL DOCUMENT v3.21.2
Unaudited Condensed Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Cumulative Effect Period Of Adoption Adjusted Balance
Retained Earnings
Cumulative Effect Period Of Adoption Adjusted Balance
Common stock
Additional Paid-in Capital
Treasury Stock
Retained Earnings
Accumulated Other Comprehensive Income (Loss)
ATM Offering
Total
Beginning balance (in shares) at Dec. 31, 2019     59,497,759   20,220,227        
Beginning balance at Dec. 31, 2019 $ (640) $ (640) $ 1 $ 528,272 $ (155,947) $ 172,265 $ (1,096)   $ 543,495
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Issuance of common stock under employee plans, net (in shares)     315,404            
Issuance of common stock under employee plans, net       (5,162)         (5,162)
Stock-based compensation       20,195         20,195
Net income (loss)           4,074     4,074
Foreign currency translation adjustments             (2,372)   (2,372)
Ending balance (in shares) at Mar. 31, 2020     59,813,163   20,220,227        
Ending balance at Mar. 31, 2020     $ 1 543,305 $ (155,947) 175,699 (3,468)   559,590
Beginning balance (in shares) at Dec. 31, 2019     59,497,759   20,220,227        
Beginning balance at Dec. 31, 2019 $ (640) $ (640) $ 1 528,272 $ (155,947) 172,265 (1,096)   543,495
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net income (loss)                 (27,558)
Foreign currency translation adjustments                 (456)
Ending balance (in shares) at Sep. 30, 2020     63,548,081   20,220,227        
Ending balance at Sep. 30, 2020     $ 1 908,584 $ (155,947) 144,067 (1,552)   895,153
Beginning balance (in shares) at Mar. 31, 2020     59,813,163   20,220,227        
Beginning balance at Mar. 31, 2020     $ 1 543,305 $ (155,947) 175,699 (3,468)   559,590
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Issuance of common stock (in shares)     3,450,000            
Issuance of common stock       306,779         306,779
Issuance of common stock under employee plans, net (in shares)     134,571            
Issuance of common stock under employee plans, net       (310)         (310)
Stock-based compensation       33,835         33,835
Issuance of common stock for business combination contingent consideration (in shares)     70,613            
Net income (loss)           (30,759)     (30,759)
Foreign currency translation adjustments             678   678
Ending balance (in shares) at Jun. 30, 2020     63,468,347   20,220,227        
Ending balance at Jun. 30, 2020     $ 1 883,609 $ (155,947) 144,940 (2,790)   869,813
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Issuance of common stock under employee plans, net (in shares)     79,734            
Issuance of common stock under employee plans, net       (1,119)         (1,119)
Stock-based compensation       26,094         26,094
Net income (loss)           (873)     (873)
Foreign currency translation adjustments             1,238   1,238
Ending balance (in shares) at Sep. 30, 2020     63,548,081   20,220,227        
Ending balance at Sep. 30, 2020     $ 1 908,584 $ (155,947) 144,067 (1,552)   895,153
Beginning balance (in shares) at Dec. 31, 2020     63,766,555   20,220,227        
Beginning balance at Dec. 31, 2020     $ 1 962,159 $ (155,947) 169,901 141   976,255
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Issuance of common stock under employee plans, net (in shares)     906,536            
Issuance of common stock under employee plans, net       (7,045)         (7,045)
Stock-based compensation       89,610         89,610
Net income (loss)           (47,917)     (47,917)
Foreign currency translation adjustments             1   1
Ending balance (in shares) at Mar. 31, 2021     64,673,091   20,220,227        
Ending balance at Mar. 31, 2021     $ 1 1,044,724 $ (155,947) 121,984 142   1,010,904
Beginning balance (in shares) at Dec. 31, 2020     63,766,555   20,220,227        
Beginning balance at Dec. 31, 2020     $ 1 962,159 $ (155,947) 169,901 141   976,255
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net income (loss)                 (46,510)
Foreign currency translation adjustments                 (1,161)
Ending balance (in shares) at Sep. 30, 2021     67,577,868   20,220,227        
Ending balance at Sep. 30, 2021     $ 1 1,147,478 $ (155,947) 123,391 (1,020)   1,113,903
Beginning balance (in shares) at Mar. 31, 2021     64,673,091   20,220,227        
Beginning balance at Mar. 31, 2021     $ 1 1,044,724 $ (155,947) 121,984 142   1,010,904
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Issuance of common stock under employee plans, net (in shares)     1,001,255            
Issuance of common stock under employee plans, net       (3,268)         (3,268)
Stock-based compensation       137,549         137,549
Net income (loss)           (47,117)     (47,117)
Foreign currency translation adjustments             (369)   (369)
Ending balance (in shares) at Jun. 30, 2021     65,674,346   20,220,227        
Ending balance at Jun. 30, 2021     $ 1 1,179,005 $ (155,947) 74,867 (227)   1,097,699
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Issuance of common stock (in shares)     577,956         577,956  
Issuance of common stock       105,615         105,615
Issuance of common stock under employee plans, net (in shares)     1,325,566            
Issuance of common stock under employee plans, net       (172,204)         (172,204)
Stock-based compensation       35,062         35,062
Net income (loss)           48,524     48,524
Foreign currency translation adjustments             (793)   (793)
Ending balance (in shares) at Sep. 30, 2021     67,577,868   20,220,227        
Ending balance at Sep. 30, 2021     $ 1 $ 1,147,478 $ (155,947) $ 123,391 $ (1,020)   $ 1,113,903